Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Dr. Reddy's Laboratories shares fall 3% on semaglutide batch concerns, supply delay
Dr. Reddy's also warned that until the issue is resolved, commercial supplies of the product will be delayed for a certain period of time, while also clarifying that there is no impact on patient safety or on the product's existing global regulatory filings.
India needs innovation at scale to fulfill ambition of becoming global discovery hub: Dr Reddy's
India must shift from minor advancements to large-scale innovation to become a global discovery hub, according to Dr. Reddy's Laboratories Chairman Satish Reddy. He emphasized the need for robust translational research pathways to ensure scientific breakthroughs benefit patients. The company's white paper highlights that stronger collaboration between academia, industry, and government is crucial for translating research into accessible healthcare solutions and overcoming existing challenges.
Buy, Sell Or Hold: IRCTC, SBI, Hindustan Copper, M&M, Paras Defence, Dr Reddy's Laboratories — Ask Profit
Buy Sell Hold
Stocks to Watch for May 21: Aditya Birla Capital, Dr Reddy's Lab, Jubilant Food, Bosch India and more
From Dr Reddy's Laboratories announcing the launch of its oral semaglutide biosimilar in India under the brand name Obeda to Whirlpool of India Ltd reporting a 32.7% year-on-year decline in net profit Q4, here are some stocks to track ahead of Thursday trading session.
Margin revival, Semaglutide launch to drive Dr Reddy’s growth momentum in FY27
Dr Reddy's Laboratories anticipates a gradual recovery this fiscal year. The company faced a profit drop last year due to US business pressures. However, operations in India, Europe, and emerging markets show healthy growth. New launches like Semaglutide and Abatacept are expected to drive future expansion. Margins are set to improve with better product mix and cost controls.
Q4 Results LIVE Updates: Dr. Reddy's, Dixon report results today; Indian Hotels, Anant Raj react
Q4 Results LIVE Updates: Its an earnings-heavy day on the Dalal Street today. Nifty 50 stock Dr Reddy's Laboratories is scheduled to report its numbers today. Dixon Tech, Berger Paints, Nazara Tech, INOX India, Cohance Lifesciences, Gopal Snacks, Kalpataru, KPR Mill, Max Financial Services, MobiKwik, MTAR Tech, Novartis, Pfizer, Religare, Keystone Developers, Sagility, Tata Power, Torrent Power, Texmaco Rail, V-Guard Industries, are among the other important results to track today. Watch this space for all the LIVE earnings updates.
SEC closes probe into alleged improper payments by Dr. Reddy’s, no enforcement action recommended
Dr. Reddy's Laboratories Ltd announced the SEC has concluded its probe into alleged improper payments in Ukraine, with no enforcement action recommended, but future action remains possible. Shares of Dr. Reddy's Laboratories Ltd ended marginally lower on Tuesday, February 24, by 0.57% at ₹1,300.00 on the NSE.
Closing Bell: Nifty crosses 24,200, Sensex surges 1,264 pts on renewed hopes of US-Iran peace talks
Interglobe Aviation, Max Healthcare, Power Grid Corp, Wipro, Eternal were among biggest gainers on the Nifty, while losers were Dr Reddy's Laboratories, Bharti Airtel, ICICI Bank. All the sectoral indices ended in the green with Capital Goods, Oil & Gas, Power, Infra, Media, Realty, Consumer Durables, IT rise 2% each. Nifty Midcap and Smallcap indices up more than 2 percent each.
Taking Stock: Nifty ends above 24,200, Sensex up 1,264 points; all sectors rally
Interglobe Aviation, Max Healthcare, Power Grid Corp, Wipro, Eternal were among biggest gainers on the Nifty, while losers were Dr Reddy's Laboratories, Bharti Airtel, ICICI Bank.
Stocks to Watch Today: RITES, GNFC, IRB Infra, Tata Power, Dr Reddys Labs, Max Estates, Meesho, Kwality Walls, PB Fintech in focus on 9 March
Stocks to Watch, 9 March: Stocks like Kwality Walls India, SML Mahindra, Max Estates, Meesho, Kotak Mahindra Bank, R Systems International, Yes Bank, Dr Reddy's Laboratories, Tata Power Company, RITES, UltraTech Cement, and IRB Infrastructure Developers will be in focus on March 9.